The Global Healthcare Contract Research Organization Market size was estimated at USD 50.92 billion in 2022, USD 56.86 billion in 2023, and is projected to grow at a CAGR of 11.80% to reach USD 124.30 billion by 2030.
Find out more: Healthcare Contract Research Organization Market Research Report - Global Forecast 2023-2030
Report Highlights:
- Based on Type, the market is studied across Clinical, Drug Discovery, and Pre-Clinical. The Clinical is further studied across Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, and Phase IV Trial Services. The Drug Discovery is further studied across Lead Identification, Lead Optimization, and Target Validation.
- Based on Service, the market is studied across Bio-Statistics, Clinical Monitoring, Data Management, Investigator Payments, Laboratory, Medical Writing, Patient & Site Recruitment, Project Management/Clinical Supply Management, Quality Management/ Assurance, Regulatory/Medical Affairs, and Technology.
- The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Healthcare Contract Research Organization Market. The Global Healthcare Contract Research Organization Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.
- The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others.
Companies mentioned in the report include:
Advanced Clinical
Charles River Laboratories, Inc.
Eurofins Scientific SE
ICON plc
IQVIA Inc.
KCR S.A.
Labcorp Drug Development
Medpace, Inc.
Parexel International Corporation
Pharmaron
PPD LLC by Thermo Fisher Scientific Inc.
SGS Société Générale de Surveillance SA
Syneos Health
Syngene International Limited
WuXi AppTec